Healthscore 601·6 metrosupdated 4h ago
FDA Approves Over-the-Counter Naloxone Nasal Spray to Fight Opioid Overdoses
The FDA has approved Rextovy, an over-the-counter naloxone nasal spray, allowing consumers to purchase it without a prescription. This move aims to enhance access to life-saving medication amid the ongoing opioid crisis.
Where it's breaking
Local coverage
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.